Natera, Inc.
NTRA- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001604821
In the last 90 days, Natera, Inc. insiders filed 0 open-market purchases and 32 sales; 850 institutions reported holding it in 13F filings for Q2 2026, worth $37.2B in total; 5 superinvestors hold it, including Duquesne Family Office and Coatue Management.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Natera, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 32 filings
- 8 insiders, $91.4M in total
- Insiders trading
- 8
- Net value
- −$91.4M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Natera, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Chapman Steven Leonard | CEO AND PRESIDENT | 96,926 | Oct 2, 2026 | 18 |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | 106,914 | Oct 2, 2026 | 23 |
| Sheena Jonathan | Director, Other: CO-FOUNDER | 9,000Indirect | Sep 25, 2026 | 32 |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | 0Indirect | Sep 16, 2026 | 15 |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER | 197,257 | Aug 28, 2026 | 15 |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | 51,637 | Aug 5, 2026 | 13 |
| Rabinowitz Daniel | SEC. AND CHIEF LEGAL OFFICER | 170,073 | Aug 5, 2026 | 17 |
| Chapman Rowan E | Director | 4,663 | Jul 17, 2026 | 8 |
| Botha Roelof | Director | 4,585 | Jun 30, 2026 | 6 |
| Rosenman Herm | Director | 5,927 | Jun 30, 2026 | 5 |
| Lynch Thomas J. Jr. | Director | 1,905 | Jun 30, 2026 | 1 |
| Baynes Roy D. | Director | 20,158 | Jun 30, 2026 | 5 |
| Marcus Gail Boxer | Director | 7,852 | Jun 30, 2026 | 5 |
| Bertagnolli Monica | Director | 7,020 | Jun 30, 2026 | 4 |
| Rubin Eric | Director | 2,204 | Jun 30, 2026 | 3 |
| Brinkley Ruth Williams | Director | 5,475 | Apr 28, 2026 | 3 |
| Healy James | Director | 46,260 | Apr 29, 2025 | 0 |
| Schueren Robert Alan | CHIEF OPERATING OFFICER | 24,091 | Jan 31, 2023 | 0 |
| Cozzens Todd C | Director | 15,813 | May 27, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 (view filing)9:35 PM ET | Aug 3-4 | 2 days | Brophy Michael BurkesCHIEF FINANCIAL OFFICER | SSale | −795 | $271.74 | −$216.0K | −1.5%51.6K after | 2 lots10b5-1 |
| Aug 7, 2026 (view filing)9:35 PM ET | Aug 7 | Same day | Sheena JonathanDirector, Other: CO-FOUNDER | SSale | −9.15K | $315.66 | −$2.89M | −3.7%236.5K after | 10 lots10b5-1 |
| Aug 7, 2026 (view filing)9:35 PM ET | Aug 7 | Same day | Rabinowitz MatthewEXECUTIVE CHAIRMAN | SSale | −2.00K | $320.90 | −$641.8K | −50.0%2.00K after | 10b5-1 |
| Aug 14, 2026 (view filing)9:35 PM ET | Aug 10 | 4 daysLate | Sheena JonathanDirector, Other: CO-FOUNDER | SSale | −6.00K | $325.32 | −$1.95M | −2.5%230.5K after | 10b5-1 |
| Aug 28, 2026 (view filing)9:35 PM ET | Aug 10 | 18 daysLate | Fesko JohnPRESIDENT, CHIEF BUS. OFFICER | SSale | −6.52K | $321.53 | −$2.10M | −3.2%197.3K after | 10b5-1 |
| Sep 3, 2026 (view filing)9:05 PM ET | Sep 1 | 2 days | Chapman Steven LeonardCEO AND PRESIDENT | SSale | −1.70K | $320.99 | −$545.0K | −1.7%98.2K after | 10b5-1 |
| Sep 3, 2026 (view filing)9:35 PM ET | Sep 1-2 | 2 days | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | SSale | −18.2K | $325.88 | −$5.92M | −14.1%110.9K after | 4 lots10b5-1 |
| Sep 11, 2026 (view filing)9:35 PM ET | Sep 11 | Same day | Rabinowitz MatthewEXECUTIVE CHAIRMAN | SSale | −50.0K | $327.97 | −$16.4M | −2.2%2.23M after | 6 lots10b5-1 |
| Sep 16, 2026 (view filing)9:35 PM ET | Sep 14-15 | 2 days | Rabinowitz MatthewEXECUTIVE CHAIRMAN | SSale | −100.0K | $340.97 | −$34.1M | −4.5%2.13M after | 28 lots10b5-1 |
| Sep 16, 2026 (view filing)9:35 PM ET | Sep 15 | 1 day | Rabinowitz MatthewEXECUTIVE CHAIRMAN | SSale | −2.00K | $350.01 | −$700.0K | −100.0%0 after | 10b5-1 |
| Sep 17, 2026 (view filing)9:35 PM ET | Sep 15-16 | 2 days | Sheena JonathanDirector, Other: CO-FOUNDER | SSale | −9.15K | $351.49 | −$3.22M | −4.0%221.3K after | 7 lots10b5-1 |
| Sep 25, 2026 (view filing)9:35 PM ET | Sep 23 | 2 days | Sheena JonathanDirector, Other: CO-FOUNDER | SSale | −18.1K | $388.01 | −$7.01M | −66.7%9.00K after | 12 lots10b5-1 |
| Oct 2, 2026 (view filing)9:35 PM ET | Oct 1 | 1 day | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | SSale | −3.00K | $414.22 | −$1.24M | −2.7%106.9K after | 3 lots10b5-1 |
| Oct 2, 2026 (view filing)9:35 PM ET | Oct 1 | 1 day | Chapman Steven LeonardCEO AND PRESIDENT | SSale | −1.27K | $413.31 | −$526.1K | −1.3%96.9K after | 10b5-1 |